This is in line with data showing the critical role of TLR4 and NF-κB activation in HIF-1α activation during trauma/hemorrhagic shock-induced acute lung injury after lymph infusion in wild-type mice, in comparison to mice that harbor a TLR4 mutation and/or NF-κB inhibitors [133]. The gene discussed is NFKB1; the disease is Shock.